Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Sodium-glucose Co-transporter-2 Inhibitors”

48 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 48 results

Not applicableUnknownNCT05993897
What this trial is testing

Effect of Sodium Glucose Co-transporter 2 Inhibitors on Left Atrial Remodeling

Who this might be right for
Atrial Fibrillation
Aswan University 60
Post-approval studies (Phase 4)WithdrawnNCT04531397
What this trial is testing

Efficacy and Safety of Dapagliflozin in Children With Proteinuric Chronic Kidney Disease

Who this might be right for
ProteinuriaChronic Kidney Diseases
Children's Hospital of Fudan University
Post-approval studies (Phase 4)Study completedNCT03977116
What this trial is testing

Sodium-glucose Co-transporter 2 Inhibitors Effects in Failing Heart Patients

Who this might be right for
Diabetes MellitusHeart FailureVentricular Arrythmia
University of Campania Luigi Vanvitelli 100
Post-approval studies (Phase 4)Ended earlyNCT05346653
What this trial is testing

The Hemodynamic Effects of SGLT2i in Acute Decompensated Heart Failure

Who this might be right for
Acute Decompensated Heart Failure
University of Chicago 1
Not applicableStudy completedNCT07302464
What this trial is testing

Sodium Glucose Co-Transporter 2 Inhibitors on Estimated Glomerular Filtration Rate in Diabetic Versus Non-Diabetic Chronic Kidney Disease Patients

Who this might be right for
Sodium Glucose Co-Transporter 2 InhibitorsEstimated Glomerular Filtration RateDiabetes+1 more
Ain Shams University 60
Post-approval studies (Phase 4)Study completedNCT03226457
What this trial is testing

SGLT2 Inhibition in Combination With Diuretics in Heart Failure

Who this might be right for
Heart FailureType 2 Diabetes Mellitus
University of Dundee 23
Not applicableActive Not RecruitingNCT06453577
What this trial is testing

Pharmacokinetics of Bisoprolol and SGLT2i in Acutely Decompensated Heart Failure

Who this might be right for
Acute Decompensated Heart Failure
Universität des Saarlandes 12
Very early researchStudy completedNCT06812429
What this trial is testing

Effects of Sodium-Glucose Co-transporter 2 Inhibitors on Inflammation

Who this might be right for
Inflammation
Washington University School of Medicine 6
Post-approval studies (Phase 4)Not Yet RecruitingNCT07323524
What this trial is testing

Dapagliflozin in Active Lupus Nephritis

Who this might be right for
Lupus Nephritis (LN)
Brigham and Women's Hospital 33
Large-scale testing (Phase 3)Study completedNCT07344922
What this trial is testing

SGLT2 Inhibitors in Non-Diabetic CKD: Effects on Vascular Calcification and Anemia

Who this might be right for
Chronic Kidney DiseaseAnemiaCardiovascular Calcification
Mansoura University 100
Large-scale testing (Phase 3)Not Yet RecruitingNCT06405178
What this trial is testing

Adjuvant Therapy With Letrozole in Induction of Ovulation With Polycystic Ovarian Syndrome

Who this might be right for
Polycystic Ovary
Beni-Suef University 500
Testing effectiveness (Phase 2)UnknownNCT06113900
What this trial is testing

Assessment of Safety and Efficacy of SGLT2is Among LN Patients

Who this might be right for
Lupus Nephritis
Ain Shams University 50
Post-approval studies (Phase 4)Study completedNCT02653482
What this trial is testing

Dapagliflozin Effect on Symptoms and Biomarkers in Patients With Heart Failure

Who this might be right for
Chronic Heart Failure With Reduced Systolic Function
Saint Luke's Health System 263
Not applicableUnknownNCT03917758
What this trial is testing

Antidiuretic Function Before and During Treatment With SGLT2 Inhibitors

Who this might be right for
Diabetes Mellitus, Type 2Arterial HypertensionBody Weight Changes
University of Turin, Italy 30
Post-approval studies (Phase 4)UnknownNCT03573102
What this trial is testing

Effect of Sodium Glucose co Transporter 2 Inhibitor ( SGLT2) on Proteinuria in Diabetic Patients

Who this might be right for
Diabetic Nephropathies
Nahla H Tohami 60
Testing effectiveness (Phase 2)Study completedNCT05570305
What this trial is testing

Zibotentan and Dapagliflozin in Patients With Type 2 Diabetes and Elevated Albuminuria

Who this might be right for
Chronic Kidney Diseases
University Medical Center Groningen 42
Very early researchLooking for participantsNCT06430684
What this trial is testing

Feasibility Trial of Sodium-GLucose CoTransporter 2 INhibitors in Pediatric Chronic KIDney DiSease

Who this might be right for
Chronic Kidney DiseasesPediatric Kidney Disease
Ann & Robert H Lurie Children's Hospital of Chicago 40
Post-approval studies (Phase 4)Study completedNCT05735197
What this trial is testing

Effect of Dapagliflozin on Renal Outcomes and Bone Mineral Disease in Non-diabetic Chronic Kidney Disease Patients

Who this might be right for
Chronic Kidney DiseasesBone Diseases, Metabolic
Mansoura University 100
Large-scale testing (Phase 3)Study completedNCT04304261
What this trial is testing

Effects of SGLT2i on the Cognitive Function in T2DM Patient (ESCDP)

Who this might be right for
Diabetes Mellitus, Type 2Cognitive Functions Confusion
Third Military Medical University 100
Not applicableActive Not RecruitingNCT05882071
What this trial is testing

Non-interventional Study (NIS) on Sodium-glucose Co-transporter-2 Inhibitors (SGLT2i) Use in France

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 547,150
Load More Results